Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 6Withdrawn 3Unknown 3Recruiting 3Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 2Genitourinary 1

Conditions

Urologic Neoplasms 1Mixed Tumor, Malignant 1Keratosis 1Carcinoma, Basal Cell 1Carcinoma 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Tomography, Optical Coherence × Clear all
NCT04510727 2024-02-20

Optical Coherence Tomography Guided C&D

University of Miami

Phase NA Withdrawn
Dermatologic

Carcinoma, Basal Cell

NCT02851693 2019-04-04

OCTSKIN

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Withdrawn
Dermatologic

Carcinoma, Keratosis, Mixed Tumor, Malignant

NCT02108587 2016-10-20

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Case Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡